CHARLES TOWN, W.Va., Jan. 9 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. , announced today that as a result of their success with silver ions in treating Molluscum Contagiosum it has expanded and reformulated those products specifically for the MRSA market.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
“As recently as 30 days ago, in December, the standard for treatment with open Molluscum lesions was to leave them open for up to two years, however because these lesions can turn into a deadly MRSA infection, mothers can no longer avoid treatment. Because of this situation our products have received new acceptance in the market place,” stated David B. Phillips, CEO of RBRM.
ReBuilder Medical Technologies, Inc. now offers a personal hygiene product line utilizing its proprietary silver ion technology to combat and protect against deadly MRSA infection. This product line includes skin ointment, liquid bandage, bar soap, liquid hand soap, shampoo, hair conditioner and mouthwash.
For more information visit: http://www.rebuildermedical.com, http://www.molluscum.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
CONTACT: Daena Carter of ReBuilder Medical Technologies, Inc.,
+1-304-725-2202
Web site: http://www.molluscum.com/
http://www.rebuildermedical.com/
